phentermine has been researched along with Dyslipidemias in 2 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity." | 9.14 | Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. ( Kang, JG; Kang, JH; Park, CY; Park, SW; Park, YW, 2010) |
| "To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity." | 5.14 | Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. ( Kang, JG; Kang, JH; Park, CY; Park, SW; Park, YW, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JG | 1 |
| Park, CY | 1 |
| Kang, JH | 1 |
| Park, YW | 1 |
| Park, SW | 1 |
| Hendricks, EJ | 1 |
| Rothman, RB | 1 |
1 trial available for phentermine and Dyslipidemias
| Article | Year |
|---|---|
Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity.
Topics: Adult; Appetite Depressants; Delayed-Action Preparations; Diabetic Angiopathies; Double-Blind Method | 2010 |
1 other study available for phentermine and Dyslipidemias
| Article | Year |
|---|---|
Phentermine therapy for obesity does not elevate blood pressure.
Topics: Appetite Depressants; Delayed-Action Preparations; Diabetic Angiopathies; Dyslipidemias; Female; Hum | 2011 |